May 2017

New Liver Disease Resource & Other Research Biobank News

Author:  Dr. Maciej Czerwinski, Michael Millhollen
Posted:  26 May 2017

Sekisui XenoTech is committed to furthering the knowledge surrounding hepatic diseases, which affects one out of four people worldwide, such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Over 20+ years of pharmacokinetic studies, we have accumulated normal and diseased tissues representing FLD with or without history of alcohol consumption and steatohepatitis in our Research Biobank.

As part of the Biobank, we have created a new fatty liver disease (FLD) progression infographic showing statistics and characteristics of tissues from normal states into steatosis, steatohepatitis and Non-alcoholic Steatohepatitis (NASH) into cirrhosis. Click here to view this new resource.

We also recently held a webinar on Drug Metabolizing Enzymes and Transporters in NASH. Click here to view this resource.

We have additionally begun offering human gallbladder tissue from matching donors with the human liver tissue samples. Furthermore, the Research Biobank donor information sheet now lists additional details, such as diabetes type, pediatric donors, and NASH donors have been listed in their own location with additional information for easier reference.

Tissues, subcellular fractions, paraffin blocks, slides & hepatocytes* are available. Learn more about the Research Biobank or contact us if you have any questions or to request a quote.

*Hepatocytes have not been prepared for all donors. Please refer to the donor information sheet for availability.

Blog post currently doesn't have any comments.
Give Feedback